Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Proceeds from Customers

2.8 / 5 stars · 68/120 Roast Me

NIAGEN BIOSCIENCE, INC. Proceeds from Customers

NIAGEN BIOSCIENCE, INC. (NAGE) reported Proceeds from Customers of $27.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromCustomers · last filed 2026-03-04

  • NIAGEN BIOSCIENCE, INC. proceeds from customers for fiscal 2025 was $27.80M, a 14.40% increase from fiscal 2024.
  • NIAGEN BIOSCIENCE, INC. proceeds from customers for fiscal 2024 was $24.30M, a 2.80% decline from fiscal 2023.
  • NIAGEN BIOSCIENCE, INC. proceeds from customers for fiscal 2023 was $25.00M, a 14.68% increase from fiscal 2022.
  • NIAGEN BIOSCIENCE, INC. proceeds from customers for fiscal 2022 was $21.80M, a 10.10% increase from fiscal 2021.
Period endProceeds from Customers 12 month
2025-12-31$27.80M
10-K · filed 2026-03-04
2024-12-31$24.30M
10-K · filed 2026-03-04
2023-12-31$25.00M
10-K · filed 2025-03-04
2022-12-31$21.80M
10-K · filed 2024-03-06
2021-12-31$19.80M
10-K · filed 2023-03-08
2020-12-31$20.00M
10-K · filed 2022-03-14
2019-12-31$13.20M
10-K · filed 2021-03-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87